ADGRD1 and osteoporosis: Given that several functionally significant single nucleotide polymorphisms (SNPs) have been identified in human populations,12 understanding GPR133/ADGRD1’s role in bone formation and mineralization is of high interest for preventing and treating both receptor deficiency-related and receptor-independent (e.g., postmenopausal) osteoporosis.